Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrence”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00040586
What this trial is testing

Phase II Trial of Monoclonal Antibody (J591) in Combination With Low-Dose Subcutaneous Interleukin-2

Who this might be right for
Prostatic Neoplasms
BZL Biologics
Large-scale testing (Phase 3)Looking for participantsNCT07207070
What this trial is testing

A Randomised, Open-label, Multicentre Phase III Clinical Study to Evaluate the Efficacy and Safety of JS105 Combined With Dalpiciclib and Fulvestrant Compared With Dalpiciclib and Fulvestrant in Patients With PIK3CA-mutated, HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer.

Who this might be right for
Breast Cancer
Risen (Suzhou) Pharma Tech Co., Ltd. 312
Testing effectiveness (Phase 2)Looking for participantsNCT06029270
What this trial is testing

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

Who this might be right for
Metastatic Nasopharyngeal CarcinomaRecurrent Nasopharyngeal CarcinomaStage IV Nasopharyngeal Carcinoma AJCC v8
National Cancer Institute (NCI) 156
Testing effectiveness (Phase 2)Study completedNCT01067469
What this trial is testing

Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)

Who this might be right for
Brain CancerGlioblastoma
M.D. Anderson Cancer Center 83
Testing effectiveness (Phase 2)Ended earlyNCT01093183
What this trial is testing

Lenalidomide and Cyclophosphamide in Treating Patients With Previously Treated Hormone-Refractory Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer
University of Nebraska 25
Not applicableActive Not RecruitingNCT07092254
What this trial is testing

Patterns of Care and Outcomes in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Daiichi Sankyo 760
Early research (Phase 1)Study completedNCT00382954
What this trial is testing

Phase I Using Velcade & Idarubicin in Elderly and Relapsed AML

Who this might be right for
Acute Myelogenous Leukemia
University of Kentucky 55
Testing effectiveness (Phase 2)Looking for participantsNCT07724405
What this trial is testing

Efficacy of Recombinant Human G-CSF in Women With Unexplained Recurrent Miscarriage

Who this might be right for
Recurrent Pregnancy LossRecurrent Miscarriages
Fakih IVF Fertility Center 150
Testing effectiveness (Phase 2)UnknownNCT03245905
What this trial is testing

Study of Chidamide as a Single-agent Treatment for Patients With Relapse or Refractory B-NHL

Who this might be right for
Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma (NHL)
Sun Yat-sen University 100
Testing effectiveness (Phase 2)Study completedNCT02312622
What this trial is testing

Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer

Who this might be right for
Stage IV Non-small Cell Lung Cancer (NSCLC)Recurrent Non-small Cell Lung Cancer (NSCLC)Extensive-stage Small Cell Lung Cancer (SCLC)+3 more
Joel Neal 27
Testing effectiveness (Phase 2)Looking for participantsNCT05756322
What this trial is testing

The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias

Who this might be right for
Relapsed or Resistant Acute Leukaemias
Lin BioScience, Inc 90
Early research (Phase 1)Looking for participantsNCT05316129
What this trial is testing

Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer
H. Lee Moffitt Cancer Center and Research Institute 10
Not applicableUnknownNCT01901731
What this trial is testing

Pelvic Embolisation to Reduce Recurrent Varicose Veins - Primary

Who this might be right for
Varicose VeinsVenous Reflux
The Whiteley Clinic 270
Testing effectiveness (Phase 2)WithdrawnNCT02355431
What this trial is testing

Itacitinib in Combination With Erlotinib in Non Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Activating Mutations

Who this might be right for
Solid Tumors and Hematologic MalignancyNSCLC (Non-small Cell Lung Carcinoma)
Incyte Corporation
Testing effectiveness (Phase 2)Study completedNCT00576979
What this trial is testing

Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

Who this might be right for
Leukemia
City of Hope Medical Center 51
Testing effectiveness (Phase 2)Study completedNCT00003796
What this trial is testing

Irofulven in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI) 32
Not applicableLooking for participantsNCT04801862
What this trial is testing

Natural History of Clostridioides Difficile Infection

Who this might be right for
Clostridium Difficile InfectionHealth Care Associated InfectionNosocomial Infection
Hospital Universitario de Valme 750
Not applicableStudy completedNCT07440888
What this trial is testing

The Factors Influencing the Success of Redo Surgery and Anal Function for Anastomosis Failure or Local Tumor Recurrence

Who this might be right for
Colo-rectal CancerAnastomosis, Leaking
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 143
Testing effectiveness (Phase 2)Study completedNCT00502203
What this trial is testing

Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus

Who this might be right for
Mixed Tumor, Mullerian
M.D. Anderson Cancer Center 23
Not applicableStudy completedNCT04436003
What this trial is testing

GDS Muscle and Articulation Chain Treatment for Chronic LBP and Spinal Stenosis

Who this might be right for
Low Back Pain, RecurrentDegenerative Disc Disease
The Hospital of Vestfold 30
Next Page